These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38796688)

  • 1. Ramosetron as an add-on therapy for refractory fibromyalgia: A randomized, double-blind, placebo-controlled trial.
    Park DJ; Jeong H; Choi SE; Kang JH; Lee JK; Lee SS
    Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38796688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ; Myers RR
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of add-on transcranial direct current stimulation on pain in Korean patients with fibromyalgia.
    Kang JH; Choi SE; Park DJ; Xu H; Lee JK; Lee SS
    Sci Rep; 2020 Jul; 10(1):12114. PubMed ID: 32694653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
    Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y
    Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Clauw D; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    J Rheumatol; 2010 Dec; 37(12):2578-86. PubMed ID: 20843911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of palonosetron versus ramosetron on preventing opioid-based analgesia-related nausea and vomiting after lumbar spinal surgery: a prospective, randomized, and double-blind trial.
    Roh GU; Yang SY; Shim JK; Kwak YL
    Spine (Phila Pa 1976); 2014 Apr; 39(9):E543-9. PubMed ID: 24480956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Tomita T; Fukui H; Morishita D; Mori S; Oshima T; Shinzaki S; Miwa H
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
    Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
    J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a prospective, randomized, double-blind, placebo-controlled, dose-ranging trial to determine the effective dose of ramosetron for the prevention of vomiting after tonsillectomy in children.
    Fujii Y; Tanaka H
    Clin Ther; 2003 Dec; 25(12):3135-42. PubMed ID: 14749151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
    Qi Q; Zhang Y; Chen F; Zuo X; Li Y
    BMC Gastroenterol; 2018 Jan; 18(1):5. PubMed ID: 29310568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain.
    Haus U; Varga B; Stratz T; Späth M; Müller W
    Scand J Rheumatol Suppl; 2000; 113():55-8. PubMed ID: 11028833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults.
    Johnson MI; Claydon LS; Herbison GP; Jones G; Paley CA
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012172. PubMed ID: 28990665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea.
    Ida M; Nishida A; Akiho H; Nakashima Y; Matsueda K; Fukudo S
    Biopsychosoc Med; 2017; 11():8. PubMed ID: 28331539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
    Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
    J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
    Ohta H; Oka H; Usui C; Ohkura M; Suzuki M; Nishioka K
    Arthritis Res Ther; 2012 Oct; 14(5):R217. PubMed ID: 23062189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a randomized, double-blind, placebo-controlled withdrawal study.
    Mease PJ; Clauw DJ; Trugman JM; Palmer RH; Wang Y
    J Pain Res; 2014; 7():679-87. PubMed ID: 25473309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous, oral, and the combination of intravenous and oral ramosetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, controlled trial.
    Ryu JH; Jeon YT; Hwang JW; Oh AY; Moon JY; Ro YJ; Kim CS; Chen C; Apfel CC; Do SH
    Clin Ther; 2011 Sep; 33(9):1162-72. PubMed ID: 21856001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women.
    Fukudo S; Kinoshita Y; Okumura T; Ida M; Akiho H; Nakashima Y; Nishida A; Haruma K
    Gastroenterology; 2016 Feb; 150(2):358-66.e8. PubMed ID: 26551550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.